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ABSTRACT:
Short interfering RNA (siRNA) is a class of nucleotide drugs with a profound potential to improve patient health through its ability to silence the expression of specific genes at the posttranscriptional level. However, the clinical application of siRNA therapeutics remains hindered by a lack of efficient delivery systems that deposit siRNA into the cytoplasm of cells, a step necessary for siRNA's silencing effect. Much research has focused on the development of siRNA delivery agents to overcome this challenge. There are no standard pre-clinical models for testing of siRNA delivery agents, and investigators have chosen to evaluate efficacy in a variety of systems including in vitro tissue culture and animal models. These systems have vastly different cellular microenvironments which may modulate cellular behavior and affect the response of cells to siRNA, thus altering the apparent efficacy of siRNA delivery agents. The substrate on which cells adhere is one aspect of the microenvironment that has been previously shown to alter cellular behavior. In this work, we tested the hypothesis that changing the properties of cellular adhesion substrates can change the apparent efficacy of a siRNA delivery agent. Specifically, we used a commonly employed in vitro cationic lipid siRNA delivery vector and evaluated siRNA silencing efficacy in U251 cells seeded on alginate hydrogel surfaces.
These surfaces were synthesized to have systematic variation in integrin ligand arginine-glycineaspartate (RGD) density and elastic modulus. We found that an eightfold increase in RGD content of the alginate grown substrate increased siRNA knockdown efficacy from 25 ± 12% to 52 ± 10%, with constant concentrations of siRNA and delivery agent. We found no difference in siRNA mediated knockdown efficacy over the elastic modulus range tested . These results indicate that the cell-adhesion substrate interaction can modulate siRNA protein silencing efficacy, a finding important for evaluation of siRNA therapeutics in the in vitro setting. with a focus on the difficult delivery challenges that hinder its translation to the clinic.
Subsequently, past work on adhesion substrate microenvironment induced alteration of cellular behavior is explored. In particular, the role of two adhesion substrate properties -integrin ligand availability and mechanical stiffness-are covered in detail. Alginate hydrogels are then introduced in order to justify use of this well validated model extracellular matrix system in the presented experiments. Previous findings exploring the related phenomenon of alginate hydrogel adhesion substrate effects on DNA delivery is discussed in depth. The section concludes with a brief description of this project's aims in relationship to past findings.
A brief history of short interfering RNA (siRNA)
Driven by its immense promise of clinical usefulness, exploration of RNA interference (RNAi) has proceeded quickly in the last two decades. Specifically, this promise lies in the ability of RNAi pathways to mediate potent and specific silencing of a particular protein's expression through modulating the availability of mRNA for translation. Because the morbidity and mortality associated with many diseases results from aberrant protein levels, the ability of RNAi based therapeutics to silence protein expression could alleviate symptoms and progression in a vast array of illnesses [1] . RNAi mechanisms have also found use in other areas where modulation of mRNA levels can alter cellular behavior including tissue engineering and developmental biology [2] [3].
Today, RNAi mechanisms are considered 'common knowledge' and widely exploited in biological laboratories. However, observations now attributed to RNAi initially puzzled researchers. For instance, investigators in the early 1990's attempted to enhance the depth of petunia petal color by introducing colored pigment genes. Instead of yielding more deeply colored flowers, the investigators found the opposite. Specifically, the generated flowers had areas of white on their petals where pigment production was completely inhibited. Similarly unusual, unexplained findings were observed in other plant and animal studies [4] [5]. It was not until Fire and Mello's 1998 experiments on C. Elegans that an accurate hypothesis for this phenomenon was identified. Specifically, they proposed that short pieces of double-stranded mRNA could operate post-transcriptionally to silence genes [6] . This hypothesis and their findings won them the 2006 Nobel Prize in Medicine, in addition to initiating the rapid development of the RNAi field [5] . With ensuing years, it has become clear that RNAi is an evolutionary ancient mechanism, conserved in many cells, including mammalian ones [7] [8]. Via the RNAi pathway, it is possible for cells to down-regulate virtually any type of protein with high specificity and potency [9] .
RNAi gene silencing mechanism
Exploration into RNAi mechanisms is ongoing. At the present time, the term RNAi is used to describe two types of post-transcriptional gene silencing: the normally exogenously induced short interfering RNA (siRNA) pathway and the endogenous microRNA pathway [9] . In the siRNA pathway, an Rnase III enzyme called Dicer recognizes long, annealed, double stranded RNA (dsRNA) and cleaves this dsRNA into smaller 21-nucleotide double stranded fragments called short interfering RNAs (siRNAs). Subsequently, a protein RNA-induced silencing complex (RISC) containing Argonaute 2 (ARGO2 or EIF2C) recognizes and binds these RNA fragments [10] . The complex then mediates degradation of the siRNA sense strand and employs the retained anti-sense strand to identify mRNA molecules with complementary sequences. Sequence specific mRNA recognition by the anti-sense strand containing RISC complex leads to cleavage of the mRNA, thus inhibiting downstream translation. This cleavage occurs in a highly stereotyped manner between the mRNA nucleotides paired with positions 10 and 11 on the guiding siRNA anti-sense strand, counting from the 5' end. After cleavage occurs, the siRNA anti-sense strand containing RISC complex is free to initiate another, new sequence specific round of mRNA cleavage. As a result of this repeated process, a sharp attenuation in the protein expression encoded by the cleaved mRNA is observed.
The second microRNA pathway of RNAi works through a similar mechanism of directed mRNA silencing. However, in contrast to the siRNA pathway, the microRNA pathways involve a dsRNA with strands of mostly, but not complete, sequence complementarity, i.e. base pair mismatch is found within these dsRNAs. This results in Dicer cleavage products of short RNA fragments possessing some mismatched base pairs with their target mRNA. Investigations into the mechanisms of action are ongoing, but this low frequency of mismatching results predominantly in RISC complex mediated translational repression as opposed to direct mRNA degradation [11] [12].
Therapeutic application of RNAi
Clearly, due to its ability to specifically silence gene expression, RNAi presents an attractive pathway for therapeutic intervention. Most investigations into the exploitation of the RNAi pathway for clinical application have involved two major approaches. The first approach involves delivery of a viral DNA vector designed to encode a specific sequence of mRNA that anneals with itself to form a hairpin loop structure. This mRNA is called a short hairpin RNA (shRNA). With the correct sequence design, the shRNA can be recognized and processed by the Dicer complex into active siRNA or microRNA components. These components can then specifically repress protein expression via the mechanisms described previously. The second approach involves the direct intracellular delivery of siRNA mimics. In this approach, double stranded 21 nucleotide RNA fragments are used to exploit the RNAi pathway at the step of RISC recognition [9] . In theory, both pathways may lead to effective therapies.
A variety of investigations at all stages are underway utilizing the RNAi mechanism.
They include siRNA based treatments for cancers, neurodegenerative conditions and viral diseases, among a variety of different illness [13] . Targets Substantial evidence exists demonstrating that cellular growth environments can significantly alter cellular behavior, including alterations important for biomacromolecule delivery. These behaviors include ligand uptake and cellular proliferation [23] . In the following discussion, the work suggesting that microenvironment can alter cellular behavior, and by extension, the cellular response to biomacromolecular therapies, will be discussed in greater detail. In several different in vitro systems, both the density of adhesion moieties and mechanical stiffness of the adhesion substrate have been shown to alter cellular proliferation.
The substrate on which cells grow influences cellular behavior
Early on, it was observed that the presentation of ECM molecules, like fibronectin, could activate intracellular signaling cascades that induced the G0/G1 transition involved in cellular proliferation [24] . Investigation revealed that these signaling cascades were activated by cell surface receptors called integrins. Integrins bind specific amino acid residues of the ECM, particularly the arg-gly-asp (RGD) amino acid sequence, and compose a large family of heterodimeric structured receptors. The alpha and beta subunits of the heterodimer both posses transmembrane and cytoplasmic domains, allowing integrins to convey extracellular changes into the intracellular space [25] . Evidence has accumulated to suggest that integrin receptor clustering can induce increased cellular proliferation [23] . Clearly, a wealth of evidence in diverse models exists to illustrate the role of adhesion substrate in controlling cellular proliferation and cellular response to secreted ligands [30] .
Because of the importance of these behaviors in siRNA delivery efficacy, it is logical to theorize that the adhesion substrate may also affect siRNA delivery efficacy via these mechanisms. The goal of this project is to examine this hypothesis.
Alginate hydrogels as controllable cellular adhesion substrates
The proposed investigation on the relationship between adhesion substrate and siRNA delivery efficacy requires a suitable model system. Alginate hydrogels offer a well-validated choice as a model substrate for the proposed experimental questions due to their controllable chemical and mechanical properties [36] . ionically bind G-blocks between adjacent alginate chains. These 'divalent bridges' result in the solidification of alginate solutions and hydrogel formation [36] . Other methods to form bridges between alginate chains have also been explored, including covalent conjugation [37] .
The low cost, relative ease of gel formation and biocompatibility of alginate hydrogels has made them attractive materials for medical applications. However, alginate itself is highly resistant to protein adsorption because of its highly hydrophilic surfaces [38] . As discussed previously, cellular adherence is critical for many cell type's survival and proliferation. Thus, alginate hydrogels alone are not good cellular adhesion substrates [36] . To remedy this, much effort has been undertaken to modify alginate hydrogels with ligands in order to support cellular attachment and thus, normal growth. Most significant among these modifications is the addition of specific cell adhesion molecule RGD peptides [39] [29] . Via this approach, aqueous carbodiimide chemistry is used to covalently attach primary amines of RGD peptides to free carboxyl groups on the alginate [29] . RGD modified alginate polymers, in contrast to their nonmodified forms, are able to support cell attachment, growth and proliferation. As a result, they have been used in many studies, including those that examine the fundamental properties governing cell/adhesion substrate interactions [29] [39] [36] .
A major advantage of RGD-modified hydrogels for use in this investigation is that they allow for control of both chemical and mechanical properties of interest. In terms of the chemical properties, modifications of the RGD chemical crosslinking procedure allows for modulation of the density of RGD molecules on the alginate surface. Changes in RGD density can alter the number of cellular receptor (integrin) and adhesion substrate (RGD ligand)
interactions. As discussed previously, integrins provide a key mechanism by which cells interact with their microenvironment and then translate environmental signals intro intracellular biochemical cascades. Thus, the density of RGD ligands on a surface presents a control point for understanding cell/material interactions [30] . In terms of the mechanical properties, by altering the concentration of Ca 2+ used in the alginate crosslinking procedure, it is possible to change the stiffness of the gel. Increasing Ca 2+ crosslinker results in a stiffer gel [29] . As discussed previously, this represents a second important control point for cell/materials interactions, since a variety of studies have shown that adhesion substrate stiffness plays a key role in cellular proliferation, differentiation and other behaviors. In this work, alginate will thus be used as an adhesion substrate that can be manipulated to examine the role of RGD density and stiffness of siRNA delivery efficacy.
Regulation of DNA delivery efficacy by adhesion substrate modification
There is precedent to believe that adhesion substrate can alter siRNA delivery efficacy, Because plasmid DNA requires introduction into the nucleus for expression and fibronectin increased proliferation, it was thought that the nuclear membrane breakdown occurring during the increased proliferation mediated the increased gene expression [43] [44] . Further work was undertaken by the Mooney Lab to more systematically examine the factors regulating adhesion substrate control of gene expression. In these experiments, RGD alginate hydrogels were used to provide RGD density and stiffness modifiable adhesion substrates. The plasmids used to transfect the cells were delivered as a noncovalent complex with cationic polymer polyethylenamine (PEI). Interestingly, increased RGD density and increased mechanical stiffness of the alginate hydrogels were able to independently increase gene expression of adherent pre-osteoblast cells. Increases in gene expression correlated with increased cellular proliferation on these adhesion substrates suggesting that again, increased plasmid access to the nucleus due to nuclear membrane breakdown during mitosis may be the mechanism by which increased gene expression occurs [30] [23].
Although siRNA is still a nucleic acid, its mechanism of action does not require nuclear entry [9] . Thus, it is of interest to explore how the same adhesion substrate factors that influence DNA gene expression can also alter siRNA expression.
Aims of study siRNA presents a potentially revolutionary class of clinically effective therapeutics.
However, like other biomacromolecule therapeutics, delivery of siRNA remains a major barrier to its use. Although much research has focused on optimizing the delivery vehicles for siRNA, considerably less is known regarding the influence of cellular adhesion substrate on siRNA mediated protein silencing. Based upon the above background evidence, it is hypothesized that altering the properties of cellular adhesion substrates can alter siRNA delivery efficacy.
Towards evaluation of this hypothesis, alginate cellular adhesion substrates will be generated with alterations in two variables: adhesion substrate RGD ligand density and substrate stiffness.
These variables and the range of values for these variables were chosen because they have previously been shown to alter the delivery efficacy other nucleic acid compounds [30] .
Subsequently, siRNA mediated knockdown of enhanced Green Fluorescent Protein (eGFP) expression in a stably transfected eGFP U251 (human glioma) cell line seeded on the different alginate substrates will be assessed to determine siRNA delivery efficacy. U251 cells were used because siRNA therapeutics may be a valuable intervention for gliomas which remain without good treatment options despite being highly invasive tumors with poor prognoses. The progression of this work can be broken in to three major aims.
1) Synthesize and characterize a series of alginate adhesion substrates.
A series of alginate polymers with variations in either the elastic modulus or the extent of RGD integrin ligand density will be synthesized. Values for the elastic moduls and RGD density will approximate those used in previous studies examining the effect of substrate on other types of nucleic acid delivery [30] . Subsequently, these adhesion substrates will be characterized prior to cellular seeding.
2) Investigate the growth and behavior of cells grown on the alginate adhesion
substrates synthesized. Differences in number and surface area of cells grown on the substrates generated in Aim 1 may alter the ability of siRNA to be endocytosed and delivered to the cytoplasm. Thus, prior to determining siRNA knockdown efficacy, analysis of the cellular properties that could alter siRNA delivery will be examined.
3) Evaluate the siRNA delivery efficacy in U251 cells cultured on the alginate adhesion substrates. To determine the ability of adhesion substrate to alter non-viral siRNA delivery, the efficacy of targeted fluorescent protein knockdown after siRNA administration for cells grown on varying alginate adhesion substrates will be evaluated. Uptake of fluorescently labeled siRNA on different substrates will also be examined to further explore any changes in siRNA knockdown efficacy. 
MATERIALS AND METHODS

Materials
Alginate hydrogel synthesis
The synthesis and mechanical characterization of RGD-modified alginate hydrogels was performed according to a previously described procedure [29] [45] . Briefly, alginate polymers were covalently conjugated to RGD peptides via EDC/SulfoNHS coupling to yield differing numbers of RGD peptide per alginate polymer (degree of substitution). For example, a gel with an average of two RGD ligands per alginate macromolecule via a previously validated synthesis scheme was designated DS 2 [29] . Calcium crosslinking was employed to form hydrogels from RGD-modified alginate. Subsequently, the elastic moduli of gels were adjusted by controlling the concentration of calcium used to form the gels. In this study, four categories of ionically crosslinked alginate hydrogels were generated for use as cellular adhesion substrates, summarized in Table 1 . 
Cell Culture
Quantification of cell growth, surface area and numbers
Four types of alginate gels were prepared with systematic variation in RGD density and elastic modulus as described in Table 1 . Gels were formed with a 1 mm thickness and 10 mm diameter. Prior to cell seeding, the gels were incubated in 0.5 mL of complete DMEM growth medium overnight in a 37°C humidified, 5% CO 2 incubator. A single gel was then transferred into one well of a 24-well plate. Subsequently, 6 x 10 4 cells/0.5 mL of growth media was added to each well to seed the gels. Fluorescent imaging was performed with a Nikon Eclipse E800 fluorescent microscope and Nikon camera attachment. Analysis of surface area distributions and cell number recorded in the fluorescent images was done with ImageJ (NIH, Bethesda, MD).
Evaluation of siRNA-mediated eGFP knockdown
Clonal eGFP U251 cells were cultured on alginate gels as described in the previous section, with the exception that media used was antibiotic free DMEM supplemented with 10% fetal bovine serum. Cells were allowed to incubate overnight in a 37°C humidified, 5% Evaluation of siRNA uptake Fluorescent AlexaFluor488 labeled siRNA was used to assess siRNA uptake. The procedure for siRNA uptake was similar to that described for the eGFP silencing siRNA and scrambled siRNA control. However, FACS analysis was done earlier to evaluate for uptake 
RESULTS
Synthesis and characterization of alginate hydrogels
Alginate hydrogels were synthesized with systematic variation in RGD peptide density and elastic modulus as shown in Table 1 . There were two levels of RGD density achieved via covalent conjugation to yield a ratio of RGD ligand to alginate polymer of either 2 or 16
(referred to subsequently as the degree of substitution or DS). An example of a typical hydrogel appearance is shown in Figure 1 .
These gels maintained their mechanical stiffness over the time course of experiments used in subsequent studies, as shown in Figure 2A . At day four of incubation, the two gels types synthesized with 50 mM and 100 mM Ca ++ had elastic moduli of 53 ± 23 kPa and 133 ± 31 kPa, respectively. Covalent modification did not alter the mechanical properties of the hydrogel, as shown in Figure 2B .
eGFP U251 cell growth characteristics on alginate substrates
The growth of U251 cells on the alginate adhesion substrates was characterized in terms of cell morphology, proliferation and surface area. Alginate hydrogel substrates used had either Finally, TCPS adherent cells had the largest average surface area of 519 µm 2 . There were no significant differences in cellular surface area for cells grown on the four different alginate substrates the fourth day after seeding, as seen in Figure 4 .
Cell number was also measured for cells growing on each of the alginate adhesion substrates. Total cell number was greatest for the alginate gels with the highest degree of substitution or RGD density, as seen in Figure 5A . However, after normalization by the number of cells present at day 1 after seeding, there was no difference in cell number amongst substrates, as seen in Figure 5B .
siRNA gene silencing efficacy on alginate substrates of varying RGD densities and elastic moduli
The effect of variations in alginate hydrogel substrate RGD density and elastic modulus on siRNA silencing efficacy in eGFP expressing U251 cells was assessed via quantification of fluorescence intensity. On the TCPS control surface, U251 cells exposed to 8.25 nM of siRNA designed to specifically silence eGFP complexed with Lipofectamine 2000 had a 44 ± 3% decrease in eGFP expression, as seen in Figure 6 . However, the same cells grown on alginate adhesion substrates did not show knockdown efficacy of siRNA at this concentration, also seen in Figure 6 . A scrambled siRNA control showed no significant eGFP expression knockdown for U251 cells grown on TCPS under the same conditions, as seen in Figure 7 .
At a higher concentration of 33 nM siRNA, the knockdown effect on cells adherent to TCPS resulted in a higher knockdown effect of 80 ± 2%, as seen in Figure 6 . This effect was predominately sequence specific because a scrambled siRNA control demonstrated only a 9% knockdown in eGFP expression, as seen in Figure 7 . At this higher concentration of siRNA, there was a significant siRNA knockdown effect for cells adherent on the alginate substrates, although the amount of knockdown effect was less than for the TCPS substrate. Normalization the knockdown percentage for TCPS and the different alginate substrates by cell surface area one day after seeding eliminated the difference in siRNA knockdown efficacy between TCPS and some, but not all, of alginate substrates.
The gel with the highest mechanical rigidity of 133 kPa and highest RGD content of DS 16
showed the highest amount of siRNA mediated knockdown. eGFP expressing cells grown on these alginate gels showed a 52 ± 12% knockdown of eGFP expression when exposed to 33 nM of siRNA. The softer gel with 53 kPa elastic modulus and the same RGD content with DS 16 demonstrated a similar 47 ± 14% knockdown effect.
Reducing the DS from 16 to 2 while keeping the elastic modulus high at 133 kPa resulted in a significant decrease in knockdown efficacy. This eightfold decrease in RGD density reduced the knockdown efficacy of the siRNA by 52% to 25 ± 10%. The softer gel with elastic modulus of 53 kPa and a low RGD density with DS 2 showed the lowest knockdown efficacy of 34 ± 6%.
Quantification of siRNA uptake on different alginate substrates
Cells grown on the different alginate substrates were also evaluated for differences in siRNA uptake. The increase in fluorescence signal from non eGFP expressing U251 cells exposed to fluorescently labeled (AlexaFluor 488) siRNA at one day after seeding was highest for cells grown on TCPS, as seen in Figure 8A . Among the alginate gels, the cells growing on the gels with the highest RGD density had the greatest siRNA uptake. Relative measurements of siRNA uptake were used to normalize the increased silencing efficacy of cells grown on the alginate substrates. Normalization by siRNA uptake eliminated the significant increase in siRNA silencing efficacy seen for between the 133 kPa/DS 2 gel and the 133 kPa/DS 16 gel, as seen in Figure 8B . There was no significant difference in uptake between cells growing on the
DISCUSSION
Synthesis and characterization of alginate hydrogels
Prior studies have shown that calcium crosslinked alginate hydrogels can decrease in stiffness over time. This occurs as the crosslinking calcium ions that hold together the guluronic acid (G) blocks of alginate polymers exchange with monovalent ions from the incubating media [46] . Because one of the goals of the presented experiments was to evaluate the siRNA silencing ability on alginate gels with varying mechanical stiffness, it was important to ensure that the mechanical stiffness of the alginate gels remained constant over the time course of subsequent experiments. Determination of the elastic modulus over the maximum time course of four days used in these studies showed that stiffness of the gels did not vary significantly over time, as seen in Figure 2A . Furthermore, covalent modification of alginate polymers with RGD did not appreciably alter the mechanical properties of hydrogels made with these modified alginates, as seen in Figure 2B .
eGFP U251 cell growth characteristics on alginate substrates
Hydrogels formed from unmodified alginate polymers do not allow for mammalian cell adhesion, and modification of the alginate with RGD is one way to promote cellular adhesion [47] . However, there is often a cell type dependent threshold limit of RGD grafting density, below which a particular cell type does not adhere to the alginate hydrogels [47] [48].
Thus, it was of interest to characterize U251 cell morphology, proliferation and surface area on the alginate hydrogels prior to evaluating siRNA knockdown efficacy.
Cells were able to adhere to gels of both DS 2 and DS 16 RGD densities, as seen in Although the total cell number was highest at day four post-seeding on the gels with the highest RGD density (DS 16), normalization to the number of cell present on the first day post seeding eliminated the significant difference in cell number for the higher RGD density substrates. This supports the conclusion that although there might be different numbers of cells initially adherent to the different substrates, cell proliferation was not necessarily increased by differences in substrate properties.
These findings are in contrast to observation in other work were cells have responded to increased growth substrate stiffness and RGD density with increased rates of proliferation.
However, these experiments were done in myoblasts and hepatocytes, so it is possible that the presented experiments differences from previous findings are due to a difference in cell type [39] [47] [48] . In particular, the U251 cell type is derived from human glioma tissue, and as a neoplastic cell line may be under reduced proliferative control by its adhesion substrate.
Alternatively, the U251 cell line may be responsive to a different range of elastic moduli of the substrate compared with myoblasts and hepatocytes.
siRNA gene silencing efficacy on alginate substrates of varying RGD densities and elastic moduli After characterizing the growth characteristics of U251 cells on the various alginate substrates, the effect of these substrates on siRNA gene silencing efficacy was tested. For these experiments, it was presumed that eGFP protein levels reflected eGFP mRNA levels, and that effective siRNA silencing would decrease both protein and mRNA amounts even though only the protein levels were examined.
The siRNA used was verified for sequence specificity by testing eGFP expression for cells exposed to both sequence-specific siRNA against eGFP and a scrambled siRNA control, as seen in Figure 7 . The sequence specific siRNA was then used to evaluate for siRNA mediated knockdown on the different growth substrates.
Results from the siRNA experiements presented in Figure 6 showed the range of elastic moduli tested (53-133 kPa) did not significantly impact the efficacy of siRNA knockdown in U251 cells. This finding contrasts with previous results demonstrating a change in DNA delivery measured by exogenously induced DNA expression in preosteoblasts dependent on the stiffness of alginate growth substrates [30] . The presented experiments cannot definitively identify the mechanistic reason for a lack of this effect in present experiments. It is possible that differences in cell lines can result in differences in the range of elastic moduli that elicit a functional response. Most organs and tissues have a modulus range from 0.1 to 100 kPa, and the alginate substrates used in the presented experiments have elastic moduli that overlap this range.
However, the U251 cells used may require further testing at an increased range of substrate stiffness to reveal changes in siRNA efficacy because they may not be responding to changes in adhesion substrates over the range of 53-133 kPa. As discussed previously with regard to proliferation patterns on the different substrates, it is also possible that U251 cell line's origin from human neoplastic tissue may make these cancer cells less responsive to extracellular matrix cues than non-neoplastic cell lines.
The TCPS substrates showed the highest efficacy of siRNA knockdown when used as a growth substrate. Perhaps these substrates' highest elastic moduli resulted in the increased silencing efficacy. Yet, TCPS has a different composition and surface character than alginate gels, and thus, it is impossible to exclude other properties of TCPS besides stiffness that may be altering siRNA efficacy.
Unlike alteration in elastic modulus, RGD density of the alginate substrates did significantly alter the siRNA mediated protein knockdown. The alginate substrates with the highest RGD density had the highest levels of siRNA mediated knockdown, as apparent from the increase in siRNA efficacy for cells grown on the DS 16 alginate gels compared to the DS 2 alginate gels both with 133 kPa elastic modulus, as seen in Figure 6 .
This difference in siRNA silencing efficacy is unlikely to be due to changes in the ratio of cell number to siRNA concentration, because the day one post-seeding density of U251 cells on the DS 2 alginate gels did not significantly differ from that on the DS 16 alginate, as seen in Figure 5 . In addition, differences in cell surface area or morphology were not observed between the DS 2 and DS 16 gels, as seen in Figures 3 and 4 , so it is unlikely that these factors accounted for the different RGD density mediated protein silencing effects observed.
In contrast to the findings for alginate gels, there was a statistically significant increase in both cell surface area and knockdown efficacy for cells grown on the TCPS substrate as compared to alginate substrates, as seen in Figure 6 . The finding that normalization of the knockdown percentage for TCPS and the different alginate substrates by cell surface area one day after seeding eliminated the difference in siRNA knockdown efficacy between TCPS and some, but not all, of alginate substrates suggests a correlation between changes in cell surface area and knockdown efficacy of siRNA. However, the fact that even after normalization for surface area, there was still a significantly increased siRNA knockdown efficacy for cells grown on the TCPS substrates and some of the alginate substrates suggests that surface area alone does not account for all of the difference in substrate effects.
Quantification of siRNA uptake on different alginate substrates
Further investigation into possible mechanisms of the increased siRNA knockdown efficacy was pursued by evaluating differences in siRNA uptake for cells grown on the different alginate substrates. The cells grown on alginate substrates with the highest RGD density demonstrated the highest siRNA uptake. In addition, normalizing for siRNA uptake eliminated the significant difference in siRNA silencing efficacy seen between the 133 kPa gels of either DS 2 or DS 16. This result suggests a correlation between increased siRNA uptake, increased siRNA silencing efficacy and increased RGD density of the substrate. However, this result does not distinguish which part of the endocytotic pathway is upregulated. Endocytosis is a multi-step process involving a variety of steps including formation of vesicles, trafficking of intracellular substances and release of cargo from vesicles [50] . More research is required to identify which exact uptake steps are affected by the increased substrate RGD density. Furthermore, these results do not preclude other mechanisms by which RGD density may modulate siRNA knockdown efficacy. Other possibilities include RGD density mediated changes in endogenous siRNA silencing protein effector complexes and/or increased intracellular siRNA stability. 
CONCLUSIONS
SUGGESTIONS FOR FUTURE WORK
The findings presented in this thesis provide several avenues for future investigation.
Two broad areas for further work include assessing the generalizability of adhesion substrate control and mechanistic investigation into siRNA delivery efficacy. Each of these directions will be discussed below with suggestions for continued experimental approaches. complexed siRNA also occurred for other modes of siRNA delivery.
Expanding on the current investigation of the effects of growth substrates into the three dimensional environment
The major motivation for the current work is to improve our understanding of how the microenvironment of cells can alter their response to siRNA, in order to determine if investigators should be considering cell adhesion substrate when choosing appropriate preclinical models for evaluation of siRNA as therapeutic. However, the use of two dimensional adhesion substrates is an approximation of cell growth in vivo, as most clinically relevant cell types normally grow within a three dimensional microenvironment.
Much recent work has shown that cell behavior can be altered by a more physiological three dimensional microenvironment, as opposed to the traditional two dimensional tissue culture substrates [58] [59]. Thus, it would be useful to extend the work done here in a two dimensional microenvironment exploring the role of RGD density and stiffness to a three dimensional culture.
This could move the applicability of the findings here to the most current in vitro models for preclinical therapeutic testing. Alginate would be well suited to this application because it has been previously used for growth of cells in three dimensional gel environments [45] [60].
Mechanistic investigation into the role of adhesion substrate control of siRNA efficacy
From the experiments undertaken, it appears that increased siRNA uptake may play a role in the increased siRNA knockdown efficacy seen for alginate gels with higher RGD density.
However, it would interesting to determine whether the increased siRNA uptake is reflective of increased internalization of other compounds. In addition, it remains unclear whether the increased uptake alone is responsible for modulating the siRNA knockdown effect or whether there may also be altered activity of the endogenous siRNA silencing protein complexes.
Although some uncertainty exists regarding the exact mechanism by which siRNA complexed to cationic lipids like Lipofectamine2000 enter cells, most agree that the process is likely endocytosis dependent. In this work, we observed increased internalization of fluorescently labeled siRNA complexed to Lipofectamine2000 in cells adherent to high RGD density alginate hydrogels. These results lead to the question of whether adhesion substrates can have more broad affects of endocytosis, not simply affecting siRNA complex uptake, but the uptake of other compounds. Specifically, since it appears that siRNA uptake is enhanced by certain adhesion substrates, it would be of interest to determine whether this increased uptake extends to other molecules. Although previous studies have mostly focused on linking adhesion substrate increased proliferation with increased delivery of biomacromolecules, it is possible that increased rates of endocytosis may also be an important factor in adhesion substrate control of biomacromolecule delivery. Although the study of endocytosis is a complex and rapidly 
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